Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar rathrbsrfng (50.14) Submitted: 5/17/2010 10:31:28 AM : Outperform Start Price: $18.67 VRX Score: +143.77

Good momentum

Featured Broker Partners


Advertisement